Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

331
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
331
Reliability and Validity01:29

Reliability and Validity

13.9K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.9K
Data Validation01:15

Data Validation

1.6K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
1.6K
Data Validation01:03

Data Validation

6.7K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.7K
Formulating and Validating Nursing Diagnosis I01:26

Formulating and Validating Nursing Diagnosis I

3.8K
A nursing diagnosis is written when the nurse recognizes a cluster of essential patient data indicating health problems treated with independent nursing interventions. The standardized terminologies of a nursing diagnosis help nurses identify and treat patients' problems. Every electronic health record that uses nursing diagnosis must employ standard diagnostic terminology. Developing an efficient, individualized care plan begins with accurate nursing diagnoses.
There are thirteen domains...
3.8K
Formulating and Validating Nursing Diagnosis II01:25

Formulating and Validating Nursing Diagnosis II

3.8K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cognitive Impairment and Chemoendocrine vs Endocrine Therapy in Pre- and Postmenopausal Women: A Secondary Analysis of the RxPONDER Randomized Clinical Trial.

JAMA oncology·2025
Same author

Novel Postneoadjuvant Prognostic Breast Cancer Staging System.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Clinical Validity of Repeated Circulating Tumor Cell Enumeration as an Early Treatment Monitoring Tool for Metastatic Breast Cancer in the PREDICT Global Pooled Analysis.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial.

Journal of the National Cancer Institute·2024
Same author

Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival.

NEJM evidence·2024
Same author

Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer.

Breast cancer research and treatment·2024
Same journal

Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation.

Molecular oncology·2026
Same journal

In vitro and in silico modelling of ROS1-positive non-small cell lung cancer reveals fusion-dependent tyrosine kinase inhibitor responses.

Molecular oncology·2026
Same journal

The role of miR-335-5p in the redifferentiation of BRAF p.V600E thyroid cancers.

Molecular oncology·2026
Same journal

EXPRESSION OF CONCERN: A Newly Identified 45-kDa JAK2 Variant with an Altered Kinase Domain Structure Represents a Novel Mode of JAK2 Kinase Inhibitor Resistance.

Molecular oncology·2026
Same journal

ZW4864-mediated inhibition of the β-catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer.

Molecular oncology·2026
Same journal

Liquid biopsy-based diagnostic evaluation of hypermethylated CpG sites for ovarian cancer diagnosis.

Molecular oncology·2026
See all related articles

Related Experiment Video

Updated: Jan 30, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

9.3K

Biomarker validation and testing.

Daniel F Hayes1

  • 1University of Michigan Comprehensive Cancer Center, 6312 CCC, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5942, USA.

Molecular Oncology
|December 3, 2014
PubMed
Summary
This summary is machine-generated.

Tumor biomarker tests guide patient care by identifying treatment needs or contraindications. Rigorous analytical validity and clinical utility are essential for reliable tumor biomarker assays to ensure better patient outcomes.

Keywords:
Level of evidenceTumor biomarkersValidation

More Related Videos

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.3K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K

Related Experiment Videos

Last Updated: Jan 30, 2026

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples
09:58

Quantitative Immunoblotting of Cell Lines as a Standard to Validate Immunofluorescence for Quantifying Biomarker Proteins in Routine Tissue Samples

Published on: January 7, 2019

9.3K
High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
09:00

High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease

Published on: October 31, 2012

16.3K
Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.8K

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Clinical Diagnostics

Background:

  • Tumor biomarkers are molecular changes indicating malignancy status.
  • Tumor biomarker tests are increasingly used to guide patient management and treatment decisions.
  • Effective use requires understanding the biomarker's role in patient care.

Purpose of the Study:

  • To define the essential criteria for the clinical application of tumor biomarker tests.
  • To emphasize the importance of analytical validity and clinical utility for biomarker assays.
  • To highlight the implications of using inadequately validated tumor biomarker tests in patient management.

Main Methods:

  • Review of the definitions and requirements for tumor biomarker assays.
  • Assessment of analytical validity (accuracy, reproducibility, reliability).
  • Evaluation of clinical utility, including evidence of improved patient outcomes or cost-effectiveness.

Main Results:

  • Few tumor biomarker tests meet the high standards for routine clinical application.
  • Analytical validity and clinical utility are critical prerequisites for guiding patient management.
  • Inadequate tumor biomarker tests can lead to negative consequences, akin to ineffective drugs.

Conclusions:

  • Tumor biomarker tests must demonstrate rigorous analytical validity and proven clinical utility.
  • Careful assessment of these criteria is essential before applying biomarker tests in clinical practice.
  • The principle 'A Bad Tumor Biomarker Test Is as Bad as a Bad Drug' underscores the need for stringent evaluation.